Article 07 May 2024 Federal Court Finds Patent For Concentrated Methotrexate Solutions Obvious Canada IP
Article 05 Mar 2024 FCA Upholds Inducement Of Infringement Findings Relating To Paliperidone Palmitate Canada IP
Article 27 Nov 2023 Federal Court Of Appeal And Federal Court Release Three Decisions Relating To Macitentan (Janssen's OPSUMIT) Canada IP
Article 01 Aug 2023 Minister Of Health Reasonable In Deciding Patent For Janssen's STELARA Was Ineligible For Listing Against SNDSs Canada IP
Article 11 May 2023 FCA Finds Teva Would Directly Infringe And Induce Infringement Of Janssen's Paliperidone Palmitate Patent Canada IP
Article 06 Mar 2023 PMPRB Releases CompassRx Annual Public Drug Plan Expenditure Report (2020/21) Canada Healthcare